Parexel International LLC

Parexel and Signify Health Collaborating to Develop New Solutions to Promote Access and Inclusion in Clinical Trials

Companies partnering to reduce social determinants of health barriers to clinical trial enrollment BOSTON, DURHAM, N.C. and DALLAS, Jan. 13, 2021 (GLOBE NEWSWIRE) -- Parexel and Signify Health...

13 janv. 2021

Parexel International LLC

Parexel Completes Separation of Parexel Informatics and Medical Imaging Business

Strategic move enhances value and growth for both companiesParexel Informatics to relaunch as Calyx BOSTON and DURHAM, N.C., Jan. 11, 2021 (GLOBE NEWSWIRE) -- Parexel, a leading provider of...

11 janv. 2021

Parexel International LLC

Parexel Names Clare Grace to Newly-Created Role of Chief Patient Officer

BOSTON and DURHAM, N.C., Jan. 04, 2021 (GLOBE NEWSWIRE) -- Parexel, a leading provider of solutions to accelerate the development and delivery of innovative therapies to improve world health, from...

04 janv. 2021

Parexel International LLC

Parexel Joins Decentralized Trials & Research Alliance (DTRA) to Enhance Patient Access, Increase Diversity and Accelerate Trial Timelines

BOSTON and DURHAM, N.C., Dec. 14, 2020 (GLOBE NEWSWIRE) -- Parexel, a leading provider of solutions to accelerate the development and delivery of innovative therapies to improve world health, from...

14 déc. 2020

Parexel International LLC

Parexel Named Best Contract Research Organization by Scrip

BOSTON and DURHAM, N.C., Dec. 03, 2020 (GLOBE NEWSWIRE) -- Parexel, a leading provider of solutions to accelerate the development and delivery of innovative therapies to improve world health, from...

03 déc. 2020

Parexel International LLC

Parexel und CTC North erhöhen gemeinsam Forschungskapazität für Durchführung früher klinischer Studien

BOSTON und DURHAM, N.C., Nov. 23, 2020 (GLOBE NEWSWIRE) -- Parexel, ein führender Anbieter von Lösungen, die die Entwicklung und Bereitstellung innovativer Therapien – von der klinischen Phase bis...

23 nov. 2020

Parexel International LLC

Parexel Partners with CTC North to Increase Research Capacity for Delivery of Early Phase Clinical Trials

BOSTON and DURHAM, N.C., Nov. 23, 2020 (GLOBE NEWSWIRE) -- Parexel, a leading provider of solutions to accelerate the development and delivery of innovative therapies to improve world health, from...

23 nov. 2020

Parexel International LLC

Parexel Announces Strategic Collaboration with Synexa Life Sciences and Drawbridge Health for COVID-19 Clinical Serology Testing Solution

BOSTON and DURHAM, N.C., Nov. 02, 2020 (GLOBE NEWSWIRE) -- Parexel, a leading provider of solutions to accelerate the development and delivery of innovative therapies to improve world health, from...

02 nov. 2020

Parexel International LLC

Parexel Biotech Collaborates with Synairgen on Pivotal Phase III Trial for Study of Inhaled COVID-19 Treatment

BOSTON and DURHAM, N.C., Oct. 20, 2020 (GLOBE NEWSWIRE) -- Parexel, a leading provider of solutions to accelerate the development and delivery of innovative therapies to improve world health, from...

20 oct. 2020

Parexel International LLC

Parexel and Innoplexus Unveil Single Source of COVID-19 Information for Researchers, Sponsors and Patients During the Pandemic

BOSTON and DURHAM, N.C. and ESCHBORN, Germany , Sept. 24, 2020 (GLOBE NEWSWIRE) -- Parexel, a leading provider of solutions to accelerate the development and delivery of innovative new therapies to...

24 sept. 2020

Résultats de la recherche

Parexel and Signify Health Collaborating to Develop New Solutions to Promote Access and Inclusion in Clinical Trials

Parexel Completes Separation of Parexel Informatics and Medical Imaging Business

Parexel Names Clare Grace to Newly-Created Role of Chief Patient Officer

Parexel Joins Decentralized Trials & Research Alliance (DTRA) to Enhance Patient Access, Increase Diversity and Accelerate Trial Timelines

Parexel Named Best Contract Research Organization by Scrip

Parexel und CTC North erhöhen gemeinsam Forschungskapazität für Durchführung früher klinischer Studien

Parexel Partners with CTC North to Increase Research Capacity for Delivery of Early Phase Clinical Trials

Parexel Announces Strategic Collaboration with Synexa Life Sciences and Drawbridge Health for COVID-19 Clinical Serology Testing Solution

Parexel Biotech Collaborates with Synairgen on Pivotal Phase III Trial for Study of Inhaled COVID-19 Treatment

Parexel and Innoplexus Unveil Single Source of COVID-19 Information for Researchers, Sponsors and Patients During the Pandemic

Réseaux de diffusion de nouvelles

À propos de nous